Literature DB >> 11857405

Overexpression of the eukaryotic translation initiation factor 4G (eIF4G-1) in squamous cell lung carcinoma.

Christine Bauer1, Nicole Brass, Isabel Diesinger, Klaus Kayser, Friedrich A Grässer, Eckart Meese.   

Abstract

eIF4G-1 belongs to the family of translational initiation factors and is recognized as the central organizing protein in recruitment of mRNA during translational initiation. Previously published studies have provided some evidence that overexpression of translational factors is a general event in the process of carcinogenesis. We have characterized the expression of the eIF4G-1 protein in 33 squamous cell carcinoma (SCC) of the lung by Western blotting. Overexpression of the eIF4G-1 protein was detected in 61% of the tumors compared to the respective normal lung tissue. In addition, we analyzed the expression of this protein by immunohistochemistry in 138 SCC of the lung using a newly generated antibody that is specific for eIF4G-1 as determined by Western blotting. This anti-eIF4G-1 antibody was suitable for the immunohistochemistry of paraffin-embedded tissues. There is a strong cytoplasmic staining detected in the tumor areas that is consistent with the cytoplasmic localization of the translation factor eIF4G-1. In 72% of the examined tissue sections of SCCs of the lung, we detected an overexpression of the eIF4G-1 protein compared to the surrounding connective tissue. Two tumors that were analyzed by both methods showed an overexpression of eIF4G-1 both with Western blot analysis and immunohistochemical staining. Overexpression of eIF4G-1 may result in an increased amount of the translation initiation complex eIF4F, which in turn may activate the translation of the same target mRNAs as eIF4E. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857405     DOI: 10.1002/ijc.10180

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Inhibition of protein synthesis by aminoglycoside-arginine conjugates.

Authors:  Marjolaine Carriere; Veerappan Vijayabaskar; Drew Applefield; Isabelle Harvey; Philippe Garneau; Jon Lorsch; Aviva Lapidot; Jerry Pelletier
Journal:  RNA       Date:  2002-10       Impact factor: 4.942

Review 2.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

Review 3.  Role of translation initiation factor 4G in lifespan regulation and age-related health.

Authors:  Amber Howard; Aric N Rogers
Journal:  Ageing Res Rev       Date:  2014-01-03       Impact factor: 10.895

4.  Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.

Authors:  Oshrat Attar-Schneider; Victoria Zismanov; Liat Drucker; Maya Gottfried
Journal:  Tumour Biol       Date:  2015-10-30

5.  Structural basis for inhibition of translation by the tumor suppressor Pdcd4.

Authors:  Nicole LaRonde-LeBlanc; Arti N Santhanam; Alyson R Baker; Alexander Wlodawer; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

6.  Differential inhibition of protein translation machinery by curcumin in normal, immortalized, and malignant oral epithelial cells.

Authors:  Nitin Chakravarti; Humam Kadara; Do-Jun Yoon; Jerry W Shay; Jeffrey N Myers; Dafna Lotan; Nahum Sonenberg; Reuben Lotan
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-09

7.  The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.

Authors:  Columba de la Parra; Elisa Otero-Franqui; Michelle Martinez-Montemayor; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

8.  Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.

Authors:  Luxia Tu; Zhen Liu; Xiufang He; Ying He; Huiling Yang; Qingping Jiang; Siming Xie; Guanghui Xiao; Xin Li; Kaitai Yao; Weiyi Fang
Journal:  Mol Cancer       Date:  2010-04-16       Impact factor: 27.401

9.  Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI.

Authors:  Oshrat Attar-Schneider; Liat Drucker; Maya Gottfried
Journal:  Lab Invest       Date:  2016-08-08       Impact factor: 5.662

10.  Novel autoantigens immunogenic in COPD patients.

Authors:  Petra Leidinger; Andreas Keller; Sabrina Heisel; Nicole Ludwig; Stefanie Rheinheimer; Veronika Klein; Claudia Andres; Jürg Hamacher; Hanno Huwer; Bernhard Stephan; Ingo Stehle; Hans-Peter Lenhof; Eckart Meese
Journal:  Respir Res       Date:  2009-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.